EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evidence of Guanidines Potential against Leishmania (Viannia) braziliensis: Exploring In Vitro Effectiveness, Toxicities and of Innate Immunity Response Effects

Luana Ribeiro Dos Anjos iD, Vanessa Maria Rodrigues de Souza, Yasmim Alves Aires Machado, Vitor Moreira Partite, Mohammed Aufy iD, Geovane Dias Lopes iD, Christian Studenik iD, Carlos Roberto Alves, Gert Lubec iD, Eduardo Rene Perez Gonzalez iD, Klinger Antonio da Franca Rodrigues iD

Biomolecules · 24.12.2023 · 14 (1) · 26

DOI: 10.3390/biom14010026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 24.12.2023. Verfasst von Luana Ribeiro Dos Anjos und 10 weiteren Autor:innen. Beteiligte Einrichtung: Fine Organic Chemistry Lab, School of Sciences and Technology, São Paulo State University (UNESP), Presidente Prudente 19060-080, Brazil. Hauptthemen laut MEDLINE: Leishmania braziliensis, Leishmaniasis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAPES, FAPESP, UNESP–MCTI-IEAMAR and FAPESP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leishmaniasis is a complex group of infectious and parasitic diseases that afflict many thousands of individuals across five continents. Leishmaniasis treatment remains a challenge because it relies on drugsknown for their high toxicity and limited efficacy, making itimperative to identify new molecules that offer greater effectiveness and safety. This study sought to explore the impact of seven synthetic guanidine derivatives (LQOF-G1, LQOF-G2, LQOF-G6, LQOF-G7, LQOF-G32, LQOF-G35 and LQOF-G36) onthe parasite Leishmania (Viannia) braziliensis and in vitro macrophage infection by this parasite, as well as cytotoxic approaches in vitro models of mammalian host cells and tissues. The synthesized compounds showed purity ≥ 99.65% and effectively inhibited parasite growth. LQOF-G1 proved the most potent, yielding the best half-maximal inhibitory concentration (IC50) values against promastigotes (4.62 μmol/L), axenic amastigotes (4.27 μmol/L), and intracellular amastigotes (3.65 μmol/L). Notably, the antileishmanial activity of LQOF-G1, LQOF-G2, and LQOF-G6 was related to immunomodulatory effects, evidenced by alterations in TNF-α, IL-12, IL-10, nitric oxide (NO), and reactive oxygen species (ROS) levels in the supernatant of culture macrophages infected with L. (V.) braziliensis and coincubated with these compounds. LQOF-G2 and LQOF-G36 compounds exhibited vasodilator and spasmolytic effects at higher concentrations (≥100 μmol/L). Generally, LQOF-G1, LQOF-G2, and LQOF-G32 compounds were found to be nontoxic to assessed organs and cells. No toxic effects were observed in human cell lines, such as HEK-293, CaCo-2 and A549, at concentrations ≥ 500 μmol/L. Collectively, data have shown unequivocal evidence of the effectiveness of these compounds against L. (V.) braziliensis parasite, one of the causative agents of Tegumentary Leishmaniasis and Mucocutaneous Leishmaniasis in America.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmania braziliensisLeishmaniasisAnimalsHumansGuanidinesCaco-2 CellsHEK293 CellsGuanidineImmunity, InnateMammals

Stichwörter der Autor:innen

Leishmania (Viannia) braziliensisguanidine derivativesimmunomodulationorgan and cell toxicity

Substanzen

GuanidinesGuanidine

Autor:innen und Institutionen

  • Fine Organic Chemistry Lab, School of Sciences and Technology, São Paulo State University (UNESP), Presidente Prudente 19060-080, Brazil.
  • Infectious Disease Laboratory-LADIC, Federal University of Parnaíba Delta-UFDPar, Campus Ministro Reis Velloso, São Benedito, Parnaíba 64202-020, Brazil.
  • Department of Pharmaceutical Sciences, Division of Pharmacology and Toxicology, University of Vienna, Josef Holaubek Platz 2, UZAII (2D 259), 1090 Vienna, Austria.
  • Laboratório de Biologia Molecular e Doenças Endêmicas, Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, 4365, Manguinhos, Rio de Janeiro 21040-900, Brazil.
  • Department of Neuroproteomics, Paracelsus Medical University, 5020 Salzburg, Austria.

ORCID-Profile: Luana Ribeiro Dos Anjos, Mohammed Aufy, Geovane Dias Lopes, Christian Studenik, Gert Lubec, Eduardo Rene Perez Gonzalez, Klinger Antonio da Franca Rodrigues

Förderung

  • CAPES
  • FAPESP
  • UNESP–MCTI-IEAMAR and FAPESP
  • CNPq
  • FAPERJ
  • FINEP

Zitieren

APA

Dos Anjos, L. R., de Souza, V. M. R., Machado, Y. A. A., Partite, V. M., Aufy, M., Dias Lopes, G., Studenik, C., Alves, C. R., Lubec, G., Gonzalez, E. R. P., & Rodrigues, K. A. D. F. (2023). Evidence of Guanidines Potential against Leishmania (Viannia) braziliensis: Exploring In Vitro Effectiveness, Toxicities and of Innate Immunity Response Effects. Biomolecules, 14(1), 26. https://doi.org/10.3390/biom14010026

Vancouver

Dos Anjos LR, de Souza VMR, Machado YAA, Partite VM, Aufy M, Dias Lopes G, et al. Evidence of Guanidines Potential against Leishmania (Viannia) braziliensis: Exploring In Vitro Effectiveness, Toxicities and of Innate Immunity Response Effects. Biomolecules. 2023;14(1):26. doi:10.3390/biom14010026

BibTeX
@article{DosAnjos2023,
  author = {Dos Anjos, Luana Ribeiro and de Souza, Vanessa Maria Rodrigues and Machado, Yasmim Alves Aires and Partite, Vitor Moreira and Aufy, Mohammed and Dias Lopes, Geovane and Studenik, Christian and Alves, Carlos Roberto and Lubec, Gert and Gonzalez, Eduardo Rene Perez and Rodrigues, Klinger Antonio da Franca},
  title = {Evidence of Guanidines Potential against Leishmania (Viannia) braziliensis: Exploring In Vitro Effectiveness, Toxicities and of Innate Immunity Response Effects},
  journal = {Biomolecules},
  year = {2023},
  volume = {14},
  number = {1},
  pages = {26},
  doi = {10.3390/biom14010026}
}
Kostenlos starten →